Cryosite Limited Stock

Equities

CTE

AU000000CTE1

Healthcare Facilities & Services

Market Closed - Australian S.E. 09:17:26 2024-06-04 pm EDT 5-day change 1st Jan Change
1.07 AUD +4.90% Intraday chart for Cryosite Limited -2.73% +76.86%
Sales 2022 11.76M 7.83M Sales 2023 11.94M 7.95M Capitalization 30.51M 20.32M
Net income 2022 1M 666K Net income 2023 1M 666K EV / Sales 2022 2.23 x
Net cash position 2022 4.49M 2.99M Net cash position 2023 3.12M 2.08M EV / Sales 2023 2.29 x
P/E ratio 2022
22.6 x
P/E ratio 2023
21.7 x
Employees 25
Yield 2022
1.59%
Yield 2023
2.4%
Free-Float 18.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.90%
1 week-2.73%
1 month+25.88%
3 months+64.62%
6 months+91.07%
Current year+76.86%
More quotes
1 week
1.02
Extreme 1.02
1.10
1 month
0.83
Extreme 0.83
1.10
Current year
0.60
Extreme 0.6
1.10
1 year
0.55
Extreme 0.55
1.10
3 years
0.33
Extreme 0.33
1.10
5 years
0.04
Extreme 0.04
1.10
10 years
0.03
Extreme 0.032
1.10
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-06-30
Director of Finance/CFO - 21-01-07
Corporate Secretary - 23-01-17
Members of the board TitleAgeSince
Director/Board Member - 11-11-20
Chairman - Dec. 07
Chief Executive Officer - 18-06-30
More insiders
Date Price Change Volume
24-06-04 1.07 +4.90% 1 896
24-06-03 1.02 -4.67% 10,000
24-05-31 1.07 -2.73% 2,098
24-05-30 1.1 0.00% 800
24-05-28 1.1 +4.76% 5,986

Delayed Quote Australian S.E., June 04, 2024 at 09:17 pm EDT

More quotes
Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.
More about the company

Annual profits - Rate of surprise